Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection

作者: K. Dalal , B. Dalal , S. Bhatia , A. Shukla , A. Shankarkumar

DOI: 10.1016/J.CCA.2019.04.072

关键词: LectinCirrhosisImmunoassayHepatitis B virusImmunologyGlycoproteomicsHepatocellular carcinomaHaptoglobinMedicineFucosylation

摘要: Abstract Background Hepatocellular carcinoma (HCC) due to Hepatitis B viral (HBV) infection is a major cause in Asia-Pacific countries. Its early detection of paramount importance using marker having both sensitivity and specificity. The present study promises diagnostic prognostic markers by the identification site-specific glycoforms on Haptoglobin (Hp) LC-MS/MS lectin ELISA liver diseased conditions HBV infection. Methods Three groups patients: chronic, cirrhosis HCC with along controls were enrolled. Hp was purified affinity column chromatography and, peptide sequence, N-glycosylation site, glycan composition identified mass spectrometry. Quantitative used measure levels fucosylation diseases HBV. Results significantly lower when compared Non-HCC cases (p  Conclusion Quantitation protein Lectin may be useful glycobiomarker either alone or combination (AFP + DCP + FucHp; AUC = 0.94) diagnosis clinical practice.

参考文章(48)
Salomé S. Pinho, Celso A. Reis, Glycosylation in cancer: mechanisms and clinical implications Nature Reviews Cancer. ,vol. 15, pp. 540- 555 ,(2015) , 10.1038/NRC3982
Yuri Takeda, Shinichiro Shinzaki, Kumiko Okudo, Kenta Moriwaki, Kohei Murata, Eiji Miyoshi, Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer Cancer. ,vol. 118, pp. 3036- 3043 ,(2012) , 10.1002/CNCR.26490
Yiwei Zhang, Jianhui Zhu, Haidi Yin, Jorge Marrero, Xin-Xiang Zhang, David M. Lubman, ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis. Journal of Proteome Research. ,vol. 14, pp. 5388- 5395 ,(2015) , 10.1021/ACS.JPROTEOME.5B00792
M R Langlois, J R Delanghe, Biological and clinical significance of haptoglobin polymorphism in humans. Clinical Chemistry. ,vol. 42, pp. 1589- 1600 ,(1996) , 10.1093/CLINCHEM/42.10.1589
Stuart M. Haslam, Alessio Ceroni, Kai Maass, Hildegard Geyer, Rudolf Geyer, Anne Dell, GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans Journal of Proteome Research. ,vol. 7, pp. 1650- 1659 ,(2008) , 10.1021/PR7008252
Xijun Wang, Aihua Zhang, Hui Sun, Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology. ,vol. 57, pp. 2072- 2077 ,(2013) , 10.1002/HEP.26130
Mayuka Shimomura, Kotarosumitomo Nakayama, Kanako Azuma, Naoko Terao, Kimihiro Nishino, Shinji Takamatsu, Miyako Nakano, Shiro Takahashi, Yuka Kobayashi, Kohei Murata, Yoshihiro Kamada, Eiji Miyoshi, Establishment of a novel lectin–antibody ELISA system to determine core-fucosylated haptoglobin Clinica Chimica Acta. ,vol. 446, pp. 30- 36 ,(2015) , 10.1016/J.CCA.2015.03.037
Ariadna Sarrats, Radka Saldova, Eva Pla, Esther Fort, David J Harvey, Weston B Struwe, Rafael de Llorens, Pauline M Rudd, Rosa Peracaula, None, Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis Proteomics Clinical Applications. ,vol. 4, pp. 432- 448 ,(2010) , 10.1002/PRCA.200900150
S. Thompson, C.A. Kelly, I.D. Griffiths, G.A. Turner, Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clinica Chimica Acta. ,vol. 184, pp. 251- 258 ,(1989) , 10.1016/0009-8981(89)90058-2